The exercise price for the warrants of series TO3 in Biosergen AB has been determined to SEK 0.49
Biosergen AB (”Biosergen” or the "Company") completed a rights issue during the first quarter of 2024, consisting of shares and warrants of series TO3. The exercise price for the warrants of series TO3 corresponds to 70 percent of the volume-weighted average price in the Company’s share on Nasdaq First North Growth Market during the measurement period, which ran from and including November 4, 2024, up to and including November 15, 2024, however not higher than SEK 0.50 and not less than SEK 0.30. During the measurement period, the volume-weighted average price in the Company’s share was
Transparency International urges G20 to deliver financial integrity reforms18 November 2024, Rio de Janeiro – As G20 member and guest countries’ heads of state and government gather in Rio de Janeiro for this week’s Leaders’ Summit, Transparency International fills the city’s sky with money to call attention to the group’s failure to address issues of corruption. Six paragliders with canopies customised with US$100-bill designs flew over Rio, ending their flight on a public beach in Rio’s Barra da Tijuca neighbourhood. They touched down on a banner which read: “How obvious should corruption
